Bioscience
Upstream Eliminates $800,000 Debt
Published in Lab Business Week, April 8th, 2007
Upstream Biosciences Inc. (OTCBB:UPBS) ("Upstream" or "the Company"), an emerging leader in the field of genetic diagnostics for cancer and the prediction of drug response, has announced that the Company has converted the debenture issued by Novar Capital Corp. Under the terms of the agreement, the debenture, and all interest accrued thereunder, was convertible at the Company's election at $1.00 per share. This conversion meets the Company's first milestone related to the recent financing announced March 5, 2007.
Upstream is developing diagnostic tests that may aid in the early detection of cancer by identifying individuals with disease susceptibility. Upstream is also...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2007-04-08)
More Articles from Lab Business Week
- Bone Research
Unigene's Site-Directed Bone Growth Technology May Have Multiple Large Market Applications According to New Market Analysis - Cancer
Ranbaxy Rewards Excellence In Medical And Pharmaceutical Research - Kirkegaard & Perry Laboratories
KPL Receives ISO 9001:2000 Registration - Life Sciences
Researchers from Kenton Laboratories provide details of new studies and findings in the area of life sciences - Life Sciences
Researchers from Moss Landing Marine Laboratories detail findings in life sciences - Marketing and Licensing Agreements
Commonwealth Drugs & Medical Supplies Co. Ltd. to Sell Jamieson Natural Supplements in the Bahamas - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
